Tumor imaging and delivery of therapeutic agents maybe achievedby designing high-affinity and high-selectivity compounds recognizinga tumor cell-expressing biomarker, such as carbonic anhydrase IX (CAIX). This evidence concerns the gene CA9 and neoplasm.